Y. Arisawa et al., SHORT-TERM INTRAHEPATIC FUDR INFUSION COMBINED WITH BOLUS MITOMYCIN-C- REDUCED RISK FOR DEVELOPING DRUG-RESISTANCE, Journal of surgical oncology, 56(2), 1994, pp. 75-80
This study evaluates tumor response, survival, and development of resi
stance to HAI chemotherapy, comparing a combination of bolus MMC and s
hort duration FUdR to short duration FUdR alone or to long duration FU
dR alone, using a rat hepatic metastases model. After intrasplenic inj
ection of 10(7) K12/TRb colon cancer cells in BD-IX rats on day 0, hep
atic metastases were evaluated and HA catheters were placed on day 14.
The response was determined on day 28. Chemosensitivity of the hepati
c metastases after HAI treatments was determined using the MTT assay.
Bolus MMC with short duration FUdR as well as long-term FUdR alone pro
vided better hepatic tumor response and survival than short-term FUdR
alone. However, bolus MMC with short duration FUdR decreased the acqui
red resistance to FUdR, compared to long-term FUdR, without causing re
sistance to MMC. These results provide a rationale for using short dur
ation of FUdR in combination with other drugs. (C) 1994 Wiley-Liss, In
c.